Qlaira is a birth control pill that is indicated to prevent pregnancy, as it acts by preventing ovulation from occurring, changes the conditions of the cervical mucus and also causes changes in the endometrium.
This contraceptive has in its composition 28 tablets of various colors, which correspond to different hormones and hormonal doses.
How to use
The contraceptive Qlaira has an adhesive calendar inside with 7 adhesive strips that show the days of the week. The strip corresponding to the day of use should be removed and pasted in the space indicated for it, so that the day of the week corresponding to the beginning is exactly above the number 1 tablet. Then, follow the direction of the arrows, until the 28 pills have been taken. In this way, the person can check whether he has taken the contraceptive correctly every day.
The use of the following card must be started the day after the end of the current card, with no pause between them and regardless of whether the bleeding has stopped or not.
To start Qlaira correctly, if the person is not using any contraceptive, they must take the first pill on the first day of the cycle, that is, on the first day of menstruation. If you are switching from another combined pill, vaginal ring or transdermal patch, you should start taking Qlaira the day after you finish taking the last active pill from the contraceptive pack you were using. The same is true for the vaginal ring or transdermal patch.
If the person is switching from a mini-pill, the Qlaira contraceptive can be started at any time. In cases of injection, implant or intrauterine system, Qlaira must be started on the scheduled date of the next injection or on the day of removal of the implant or intrauterine system, but it is important to use a condom during the first 9 days of using Qlaira.
Who should not take
Qlaira should not be used in people with a current or previous history of thrombosis, pulmonary embolism or clot formation in other parts of the body, current or previous history of heart attack or stroke or a certain type of migraine with visual symptoms, difficulty in talking, weakness or falling asleep anywhere on the body.
In addition, it is also contraindicated in people with diabetes mellitus with damage to the vascular system, current or previous history of liver disease, cancer that can develop under the influence of sex hormones or liver tumor, with unexplained vaginal bleeding, or that are pregnant or suspect a pregnancy.
In addition, this medicine should not be used in people who are allergic to estradiol valerate, dienogest or any of the components of Qlaira.
Possible side effects
The most common side effects that can occur with the use of Qlaira are emotional instability, depression, decreased or loss of sexual desire, migraine, nausea, breast pain and unexpected uterine bleeding.
In addition, although very rare, arterial or venous thrombosis may also occur.
